Ei­sai picks SEED Ther­a­peu­tics for mol­e­c­u­lar glue deal worth as much as $1.5B

Ei­sai is pay­ing SEED Ther­a­peu­tics an undis­closed amount up­front in a deal worth up to $1.5 bil­lion to de­vel­op new ‘mol­e­c­u­lar glue’-based ther­a­pies for neu­rode­gen­er­a­tive …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER